MyHealthChecked PLC (FORF) AI Stock Analysis

6 Followers

MyHealthChecked PLC

(LSE:FORF)

Select Model

Rating:46Neutral

Price Target:GBX 8.00▼(-2.44% Downside)

Action:reiterated

Date:11/05/26

The score is weighed down primarily by severely weakened financial performance (revenue collapsing to zero, multi-year losses, negative gross profit, and ongoing cash burn). Technicals are neutral with flat moving averages and muted momentum indicators, offering little offset. Valuation is also constrained by a negative P/E tied to unprofitability and no provided dividend yield.

Positive Factors

Low LeverageVery low leverage reduces interest burden and refinancing exposure, preserving financial flexibility if operations recover. The still-positive equity base gives the company some capacity to fund a restructuring or reinvestment plan without the immediate pressure of substantial debt obligations.

Negative Factors

Revenue CollapseThe prolonged revenue contraction signals a severe loss of commercial activity and customer demand, rather than a single weak reporting period. Revenue at effectively zero leaves little operating scale, weakens the platform for fixed-cost absorption, and makes near-term recovery dependent on rebuilding sales.

MyHealthChecked PLC (FORF) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: GBP 2.65M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -2.6
Beta (1Y): 0.91
Revenue Growth: ―
EPS Growth: ―
Country: UK
Employees: 13
Sector: Financial
Sector Strength: 68
Industry: Medical - Specialties

MyHealthChecked PLC Business Overview & Revenue Model

Company Description

Fortis Frontier PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. It is also involved in the development of an accompanying proprietary digital platform. The company was formerly known as MyHea...

How the Company Makes Money

MyHealthChecked generates revenue primarily by selling diagnostic and health-testing products and services. Key revenue streams typically include: (1) direct-to-consumer sales of at-home test kits (where customers purchase kits that may include sampl...

MyHealthChecked PLC Financial Statement Overview

Summary

Operating performance has deteriorated sharply: revenue fell from 22.3M (2022) to effectively zero in 2025, with losses and negative gross profit in 2024–2025. The balance sheet is a relative strength with near-zero debt and still-positive equity, but equity has been declining due to sustained losses and cash burn.

Income Statement

18Very Negative

Balance Sheet

62Positive

Cash Flow

22Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Jun 2025	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	0	0	3.61M	10.98M	22.31M	16.38M
Gross Profit	0	-215.00K	-194.00K	2.05M	4.79M	5.13M
EBITDA	-422.00K	-360.00K	-1.53M	30.00K	1.74M	2.16M
Net Income	-231.00K	-1.63M	-1.79M	-159.00K	1.52M	2.00M
Balance Sheet
Total Assets	3.53M	7.53M	8.80M	13.34M	11.43M	11.67M
Cash, Cash Equivalents and Short-Term Investments	3.48M	5.76M	5.47M	7.75M	7.61M	6.39M
Total Debt	0	0	0	26.00K	53.00K	0
Total Liabilities	38.00K	2.15M	1.83M	4.64M	2.58M	4.55M
Stockholders Equity	3.50M	5.38M	6.97M	8.70M	8.85M	7.11M
Cash Flow
Free Cash Flow	-846.00K	-1.62M	-2.26M	157.00K	1.27M	2.77M
Operating Cash Flow	-846.00K	-1.62M	-2.16M	724.00K	1.61M	3.01M
Investing Cash Flow	0	1.91M	-93.00K	-531.00K	-338.00K	-299.00K
Financing Cash Flow	-2.58M	0	-23.00K	-52.00K	-47.00K	3.21M

MyHealthChecked PLC Technical Analysis

Technical Analysis SentimentNegative

Last Price8.20

Price Trends

50DMA8.20Positive

100DMA8.20Negative

200DMA8.12Positive

Market Momentum

MACD-0.00Negative

RSI45.89Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:FORF, the sentiment is Negative. The current price of 8.20 is above the 20-day moving average (MA) of 8.20, above the 50-day MA of 8.20, and above the 200-day MA of 8.12, indicating a bullish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 45.89 is Neutral, neither overbought nor oversold. The STOCH value of is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:FORF.

MyHealthChecked PLC Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

GB:FORF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
GB:EKF	64Neutral	GBP 104.42M	41.81	3.58%	―	2.26%	-57.04%
GB:RUA	56Neutral	GBP 14.27M	-91.30	-2.03%	―	―	―
GB:IHC	48Neutral	GBP 15.92M	-26.10	-3.85%	―	0.88%	94.67%
GB:FORF	46Neutral	GBP 2.65M	-2.56	-35.76%	―	―	―
GB:SUN	42Neutral	GBP 3.73M	-4.00	-15.47%	―	-3.68%	20.00%
GB:CREO	40Underperform	GBP 46.60M	-2.29	-38.29%	―	―	―

* Financial Sector Average

Performance Comparison

GB:FORF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:FORF	MyHealthChecked PLC	8.20	-0.55	-6.29%
GB:RUA	Rua Life Sciences Plc	21.00	8.50	68.00%
GB:CREO	Creo Medical	10.38	-0.38	-3.49%
GB:EKF	EKF Diagnostics Holdings	24.25	-1.65	-6.37%
GB:IHC	Inspiration Healthcare	17.75	-2.50	-12.35%
GB:SUN	Surgical Innovations Group Plc	0.40	-0.18	-31.03%

MyHealthChecked PLC Corporate Events

Business Operations and StrategyStock BuybackDelistings and Listing ChangesFinancial Disclosures

Fortis Frontier tightens register and cash shell strategy ahead of AIM deadline

Negative

Sep 15, 2026

Fortis Frontier PLC reported unaudited half-year results for the six months to 30 June 2026, highlighting its status as a clean AIM cash shell with cash balances of £3.48m after £1.72m of share buybacks. The disposal of its former trading subsidiary...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 04, 2026

MyHealthChecked PLC AI Stock Analysis